Search results
Found 29926 matches for
Oxford, UK: 23 May, 2018: Orbit Discovery Ltd, an Oxford, UK-based biotech company developing an industry-leading peptide identification and optimisation platform, today announced the closing of a £6.9M Series A Financing. The round was led by Oxford Sciences Innovation who were joined by new investors RT Ventures, Borealis Ventures, Perivoli Innovations, along with further investment from all existing investors and Oxford University. Additionally, Borealis Managing Partner Phil Ferneau and Oxford Investment Consultants’ Partner James Mallinson join Orbit’s Board of Directors.
©
Shutterstock
Paul Johnson
MA MD FRCS (Paed.Surg) FAAP Paul Johnson - Director of Oxford Islet Isolation and Islet Transplant Programmes and Professor of Paediatric Surgery
Peter Rothwell
MD PhD FRCP Peter Rothwell - Founding Director of the Wolfson Centre for the Prevention of Stroke and Dementia and Action Research Professor of Neurology
David Jackson
B.A. (Natural Sciences), Ph.D. (Biochemistry) David Jackson - Professor of Human Immunology